1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease
申请人:Boehringer Ingelheim Pharmaceuticals, Inc.
公开号:US06414153B1
公开(公告)日:2002-07-02
Novel compounds of the formula I:
which are useful for treating or preventing inflammatory and immune cell-mediated diseases. Exemplary compounds are:
3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-1,3-dihydroindol-2-one;
3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,3-dihydro-indol-2-one;
3-benzyl-1-(3,5-dichlorophenyl)-3-methyl-1,3-dihydroindol-2-one;
3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-4-hydroxy-3-methyl-1,3-dihydroindol-2-one; and,
3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-fluoro-1,3-dihydroindol-2-one.
化合物I的新颖化合物:用于治疗或预防炎症和免疫细胞介导的疾病。示例化合物包括:3-(4-溴苄基)-1-(3,5-二氯苯基)-1,3-二氢吲哚-2-酮;3-(4-溴苄基)-1-(3,5-二氯苯基)-3-甲基-1,3-二氢吲哚-2-酮;3-苄基-1-(3,5-二氯苯基)-3-甲基-1,3-二氢吲哚-2-酮;3-(4-溴苄基)-1-(3,5-二氯苯基)-4-羟基-3-甲基-1,3-二氢吲哚-2-酮;以及3-(4-溴苄基)-1-(3,5-二氯苯基)-5-氟-1,3-二氢吲哚-2-酮。